Cart summary

You have no items in your shopping cart.

Vistusertib

SKU: orb1306966

Description

Vistusertib (AZD2014) is an orally active mTOR inhibitor with potential anticancer properties. It is used in preclinical research to study mTOR signaling in oncology, demonstrating activity in both in vitro cell-based assays and in vivo tumor models.

Research Area

Cell Biology, Signal Transduction

Images & Validation

Key Properties

CAS Number1009298-59-2
MW462.54
Purity99.06%
FormulaC25H30N6O3
SMILESCNC(=O)c1cccc(c1)-c1ccc2c(nc(nc2n1)N1CCOC[C@@H]1C)N1CCOC[C@@H]1C
TargetAkt,S6 Kinase,mTOR,Apoptosis,Autophagy,PI3K
Solubility10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.32 mM);H2O:< 1 mg/mL (insoluble or slightly soluble);Ethanol:< 1 mg/mL (insoluble or slightly soluble);DMSO:36 mg/mL (77.83 mM)

Bioactivity

Target IC50
mTOR:2.8 nM|pS6 (S235/236):200 nM|PI3Kα:3.766 μM|pAkt (S473):80 nM
In Vivo
In hormone therapy-responsive ER+ breast cancer cell lines, AZD2014 inhibits cellular growth and promotes apoptosis. It effectively suppresses the biomarkers of mTORC2, namely pAKTSer473 and pNDRG1Thr346.
In Vitro
In the human ER+ breast cancer xenograft model, AZD2014 inhibits tumor growth by regulating the substrates of mTORC1 and mTORC2.
Cell Research
AZD2014 is prepared in DMSO (10 mM) and stored under nitrogen, and then diluted with appropriate media before use. Cells are plated in 96-well plates for the indicated time. For CellTiterGlo assays: CellTiterGlo is mixed with the cells. Cells are normalized to day 0 control and net growth is determined using the following formula: ((x y)/(z y))=net growth, where x=reading of treated sample at end of study, y=average reading on day 0, and z=reading of DMSO-treated sample at end of study. The concentration of DMSO does not exceed 0.03% for any experiment. For MTS assays: adherent cell lines are grown in 96-well plates. MTS reagent is added on day 0 and on day 3 post-AZD2014 addition. Suspension lines are assayed using the Alamar Blue reagent, 72 hours after AZD2014 addition.

Storage & Handling

Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

AZD 2014, AZD2014, AZD-2014, Autophagy, Apoptosis, Mammalian target of Rapamycin, Inhibitor, P-Akt (S473), inhibit, mTOR, pS6 (S235/236), S6 Kinase, S6Kinase, PI3Kα, Vistusertib

Similar Products

  • AZD2014 [orb1227163]

    >98% (HPLC)

    1009298-59-2

    462.54

    C25H30N6O3

    500 mg, 200 mg, 100 mg, 2 mg, 5 mg, 25 mg, 1 g, 10 mg, 50 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Vistusertib (orb1306966)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

1 mg
$ 80.00
5 mg
$ 110.00
1 ml x 10 mM (in DMSO)
$ 120.00
10 mg
$ 160.00
25 mg
$ 230.00
50 mg
$ 290.00
100 mg
$ 440.00
200 mg
$ 630.00
DispatchUsually dispatched within 3-5 working days
Bulk Enquiry